Title:
PREVENTIVE AND THERAPEUTIC AGENT FOR LYSOSOMAL DISEASES
Document Type and Number:
WIPO Patent Application WO/2019/156252
Kind Code:
A1
Abstract:
The present invention provides a lysosomal disease preventive/therapeutic agent comprising an HMG-CoA reductase inhibitor.
Inventors:
SAKURAI HIDETOSHI (JP)
NISHI YOHEI (JP)
OHTA AKIRA (JP)
NISHI YOHEI (JP)
OHTA AKIRA (JP)
Application Number:
PCT/JP2019/004766
Publication Date:
August 15, 2019
Filing Date:
February 05, 2019
Export Citation:
Assignee:
UNIV KYOTO (JP)
International Classes:
A61K31/366; A61K45/00; A61P3/00; A61P21/00; A61P43/00
Domestic Patent References:
| WO2009040816A1 | 2009-04-02 | |||
| WO2010131712A1 | 2010-11-18 |
Foreign References:
| JP2017536363A | 2017-12-07 | |||
| JP2006117553A | 2006-05-11 |
Other References:
QUAN, YANG: "Lysosomal Acid Lipase Deficiency: Focus on Cholesterol Ester Storage Disease", CESD, vol. 69, no. 3, 2014, pages 445 - 453
Attorney, Agent or Firm:
TAKASHIMA, Hajime (JP)
Download PDF: